Beyond this, a recent study demonstrated that CD63+/CD9+ EVs from the saliva of patients with oral cancers have unique and discriminatory infrared signatures compared with healthy controls [71]. This evidence concerns the gene CD63 and lip and oral cavity carcinoma.